Serum levels of RBP4 and adipose tissue levels of PTP1B are increased in obese men resident in northeast Scotland without associated changes in ER stress response genes

International Journal of General Medicine

Volumn 5, Issue , 2012, Pages 403-411

  Hoggard, Nigel ^a   Agouni, Abdelali ^b   Mody, Nimesh ^b   Delibegovic, Mirela ^b  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

ATF4; BIP; Diabetes; ER stress; Glucose homeostasis; GRP94; Insulin resistance; Metformin; Obesity; PTP1B; RBP4; TTR; UPR

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ADIPONECTIN; BINDING IMMUNOGLOBULIN PROTEIN; BINDING PROTEIN; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE REGULATED PROTEIN 94; LEPTIN; METFORMIN; PREALBUMIN; PROTEIN TYROSINE PHOSPHATASE 1B; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY FAT; BODY MASS; CELLULAR STRESS RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC DIET; ENDOPLASMIC RETICULUM STRESS; ENDOPLASMIC RETICULUM STRESS RESPONSE GENE; GENE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; UNITED KINGDOM; UPREGULATION;

EID: 84877115206     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S25879     Document Type: Article

References (24)

1. Owen C, Czopek A, Agouni A, et al. Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis. PLoS One. 2012;7(2): e32700.
2. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129-139.
3. Esteve E, Ricart W, Fernandez-Real JM. Adipocytokines and insulin resistance: The possible role of lipocalin-2, retinol binding protein-4, and adiponectin. Diabetes Care. 2009;32 Suppl 2:S362-S367.
4. Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature. 2005;436(7049):356-362.
5. Graham TE, Yang Q, Bluher M, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med. 2006;354(24):2552-2563.
6. Qi Q, Yu Z, Ye X, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab. 2007;92(12):4827-4834.
7. McTernan PG, Kumar S. Editorial: Retinol-binding protein 4 and pathogenesis of diabetes. J Clin Endocrinol Metab. 2007;92(7): 2430-2432.
8. Zabolotny JM, Kim YB, Welsh LA, Kershaw EE, Neel BG, Kahn BB. Protein-tyrosine phosphatase 1B expression is induced by inflammation in vivo. J Biol Chem. 2008;283(21):14230-14241.
9. Cheng A, Uetani N, Simoncic PD, et al. Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Dev Cell. 2002;2(4):497-503.
10. Agouni A, Mody N, Owen C, et al. Liver-specif ic deletion of protein tyrosine phosphatase (PTP) 1B improves obesity-and pharmacologically-induced endoplasmic reticulum stress. Biochem J. 2011;438(2):369-378.
11. Klaman LD, Boss O, Peroni OD, et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol. 2000;20(15):5479-5489.
12. Elchebly M, Payette P, Michaliszyn E, et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999;283(5407):1544-1548.
13. Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695): 457-461.
14. Ozcan U, Yilmaz E, Ozcan L, et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006;313(5790):1137-1140.
15. Ozcan L, Ergin AS, Lu A, et al. Endoplasmic reticulum stress plays a central role in development of leptin resistance. Cell Metab. 2009;9(1):35-51.
16. Bettaieb A, Liu S, Xi Y, et al. Differential regulation of endoplasmic reticulum stress by protein tyrosine phosphatase 1B and T cell protein tyrosine phosphatase. J Biol Chem. 2011;286(11):9225-9235.
17. Graham TE, Wason CJ, Bluher M, Kahn BB. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia. 2007;50(4):814-823.
18. Hoggard N, Johnstone AM, Faber P, et al. Plasma concentrations of alpha-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation. Clin Endocrinol (Oxf). 2004;61(1):31-39.
19. Mody N, Agouni A, McIlroy GD, Platt B, Delibegovic M. Susceptibility to diet-induced obesity and glucose intolerance in the APP (SWE)/ PSEN1 (A246E) mouse model of Alzheimer's disease is associated with increased brain levels of protein tyrosine phosphatase 1B (PTP1B) and retinol-binding protein 4 (RBP4), and basal phosphorylation of S6 ribosomal protein. Diabetologia. 2011;54(8):2143-2151.
20. Mody N, Graham TE, Tsuji Y, Yang Q, Kahn BB. Decreased clearance of serum retinol-binding protein and elevated levels of transthyretin in insulin-resistant ob/ob mice. Am J Physiol Endocrinol Metab. 2008;294(4):E785-E793.
21. Agouni A, Owen C, Czopek A, Mody N, Delibegovic M. In vivo differential effects of fasting, re-feeding, insulin and insulin stimulation time course on insulin signaling pathway components in peripheral tissues. Biochem Biophys Res Commun. 2010;401(1):104-111.
22. Yao-Borengasser A, Varma V, Bodles AM, et al. Retinol binding protein 4 expression in humans: Relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab. 2007;92(7):2590-2597.
23. Makino S, Fujiwara M, Suzukawa K, et al. Visceral obesity is associated with the metabolic syndrome and elevated plasma retinol binding protein-4 level in obstructive sleep apnea syndrome. Horm Metab Res. 2009;41(3):221-226.
24. Jia W, Wu H, Bao Y, et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab. 2007;92(8):3224-3229.